by Tony Dammicci | Feb 10, 2025 | Press Releases
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025. Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) — Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) (“Invizyne”), a leading designer of cell-free, enzyme-based biomanufacturing...
by Tony Dammicci | Jan 29, 2025 | Press Releases
SANTA CLARA, Calif.–(BUSINESS WIRE)– HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application to the U.S. Food and...
by Tony Dammicci | Dec 16, 2024 | Press Releases
First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection and advanced diagnostics Patients can have the credit card-sized device with them at all times, ready to record an ECG...
by Tony Dammicci | Nov 19, 2024 | Press Releases
The studies further strengthen HeartBeam’s body of clinical evidence for its portable, cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG The first study is a pilot study demonstrating similar performance of HeartBeam’s...
by Tony Dammicci | Nov 15, 2024 | Press Releases
Addison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Thursday November 21, 2024 at 4:30 p.m....
by Tony Dammicci | Nov 13, 2024 | Press Releases
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol “IZTC” Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
Recent Comments